S
IBRX icon

SignatureFD’s ImmunityBio IBRX Stock Holding History

SignatureFD’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$2.46K – 3469
2025
Q3 		$2.46K Sell
1,000
-52
-5% -$134 ﹤0.01% 2893
2025
Q2 		$2.78K Buy
1,052
+770
+273% +$2.07K ﹤0.01% 2783
2025
Q1 		$849 Buy
+282
New +$855 ﹤0.01% 3072
2022
Q4 		– Sell
-3,845
Closed -$19K – 3339
2022
Q3 		$19K Hold
3,845
– – ﹤0.01% 1757
2022
Q2 		$14K Hold
3,845
– – ﹤0.01% 1948
2022
Q1 		$22K Hold
3,845
– – ﹤0.01% 1792
2021
Q4 		$23K Buy
+3,845
New +$28.9K ﹤0.01% 1726

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return